A Solid Vaccine Stock Ready to Pop

Biotech and pharmaceutical stocks have been in the spotlight a great deal over the last few quarters. The race to find a vaccine has produced a number of winners and losers as results for trials were announced.

The most recent winner appears to be Pfizer (PFE). The company announced trial results showing that 90% of those given the vaccine were protected from the COVID-19 virus.

One biotech company that is working with a couple of other companies on a vaccine and treatments is Amgen (AMGN). The company has partnered with Eli Lilly on their antibody therapy and it is working with Adaptive on both treatment and preventive drugs for the virus.

Despite its participation in the COVID-19 treatment and vaccine efforts, Amgen saw its stock slide in the four months.

It fell from the $260 area in early July to a low of $210.28 in the final week of October. The stock has since reversed and appears ready to resume its long-term upward trend.

Looking at the weekly chart we see a trend channel that has formed over the last few years. The lows from mid-2019 connect to form the lower rail and while the stock’s recent decline took it below that trend line, it closed the week right on it.

The only other time the stock fell below that trend line was during the market meltdown in March. We also see how the highs from last December and this past July connect with a parallel line.

Another factor that got my attention on Amgen’s chart was how the weekly stochastic indicators made a bullish crossover in the last few weeks.

In the past, when the stock has become oversold and the indicators have made a bullish crossover, we have seen extended rallies from Amgen. The rallies have produced gains between 23% and 27%. The low in March didn’t cause the indicators to reach oversold territory, but the stock rallied over 35% in two short months.

Management efficiency

While I like what is going on with the chart of Amgen, the reason it was on my radar in the first place was due to the fundamentals. The company has been able to grow earnings and revenue at a solid pace in recent years, but where the company does extremely well is with its management efficiency measurements.

The return on equity is 81.4% and that is extremely high. The average ROE tends to fall in the 15%-20% range. The profit margin is 45.5% and the average profit margin seems to be around 15%.

Despite the strong fundamentals, analysts are far less bullish on Amgen than they are the average stock. There are 29 analysts covering the stock with 13 “buy” ratings, 15 “hold” ratings, and one “sell” rating. This puts the buy percentage at 44.8% and the average buy percentage falls between 65% and 75%.

Why is it important that analysts are skeptical of the stock? When a stock has more hold and sell ratings than buy ratings, it means there is a greater chance for an upgrade or a series of upgrades that can help propel the stock higher.

Based on the previous rallies when the stochastic indicators made bullish crossovers, I look for Amgen to move up to the $265-$270 range in the next few months. With that in mind, I like the January 2021 $235-strike calls.

With the stock trading at $243.50, these options are priced at $15.95, or $1,595 for each contract. A move up to $265 would give the options an intrinsic value of $30.00 and that would mean a gain of 88% for investors.

Recommended Articles

Make Your Kid a Millionaire With This Simple IRS Program

Individual retirement accounts (IRAs) are an excellent investment option for people who are looking to save up for retirement. Contrary to what some people think, IRAs are not just meant

Legal Cannabis Now Powerful Enough to Replace Dangerous, Addictive Painkillers

Opioid abuse and addiction is a huge issue in the United States. In addition to this, long term use of these pain killers can lead to various health problems. These are

4 Great Places to Retire Near Water

The hard reality of retirement is that most people don’t plan for it until it is too late to be implemented feasibly. Or they don’t exactingly calculate how long their

Warren Buffett Learned Everything He Knows from This One Book

Value investing is the name of a particular investment philosophy that stresses a long-term approach to investing. Rather than follow short-term trends in the market, value investing relies on thorough

Exposed: Pharmaceutical Companies Spend Over 18 Billion Annually on Gifts to Doctors

I worked in a busy family physician's office about 18 years or so ago and was astounded by how many drug reps came in and out of the office loaded

6 Secrets to Getting Hired After Age 55

Finding a new job after a certain age, especially when you are in your late 50s, can prove to be quite challenging. Older workers have a lower unemployment rate than

Before You Sign, Read the Pros and Cons of Timeshares

Timeshares are upscale vacation and recreational properties that are simultaneously owned by multiple investors. However, there is a catch. Each owner is contractually obligated to only visit and inhabit the

6 Fast-Food Facts That Will Make You Put Down That Burger

Americans are more overweight than ever before. Sedentary lifestyles and poor diet is to blame. The convenience of fast food is also a factor. Morbid obesity increases the potential for

7 Common Impulse Purchases People Regret the Most

The bane of consumerism is that people voluntarily buy things that they don’t need or want for its own sake. By some estimates nearly 80% of American consumers buy some

10 Detoxifying, Filling Foods to Help You Slim Down Without Deprivation

Fad diets are a trend that may never die, as much as most of us want them to. It’s high time we took the focus off skinny and turned to

6 Ways to Get Perfectly Legit Free Government Cash

No such thing as a free lunch. Well, as a rule, yes. But we also know that for every rule, there are exceptions. While on one hand, we must beware

A Healthier You In Just a Month With These 12 New Habits

This is a simple guide to creating a healthier you in just one month! Some of these may be difficult, but the end results of feeling great are well worth